Elimbias Health
Christchurch, New Zealand
Christchurch clinic offering psilocybin-assisted treatment for treatment-resistant depression under New Zealand's Medsafe prescriber approval pathway.
Treatments offered
Psilocybin (licensed program)
Supported sessions with a trained facilitator, studied most for depression, end-of-life distress, and addiction. Legal through licensed programs in Oregon and Colorado and through authorised prescribers in Australia.
Pricing
This provider does not publish prices. Contact them directly for a quote, and ask what a full course costs rather than a single session.
Insurance and reimbursement
This provider does not state an insurance policy on its website. Ask directly whether they bill insurance or provide a superbill.
- Oregon and Colorado programs run outside the medical system, so health insurance does not apply at all.
- Expect $1,000 to $3,500 for the full arc: preparation, the administration session, and integration.
- Several centers offer sliding-scale spots or reduced-cost group sessions; it is worth asking.
Who can apply
- A diagnosis of treatment-resistant depression, assessed by the approved psychiatrist.
- Only psychiatrists with their own Medsafe approval can prescribe.
Legal basis: Individual prescriber approval, New Zealand
Psilocybin remains a Class A drug in New Zealand, but Medsafe can approve individual psychiatrists to prescribe it for treatment-resistant depression. Each approval is specific to the named prescriber.
More on legality hereSources
Where this listing's information came from. Always confirm details with the provider before booking.